IMARC: UAE medical tourism to hit $4.55bn by 2034, forcing hospital capacity calls

IMARC Group projects the UAE medical tourism market will rise from USD 865.8 million in 2025 to USD 4,547.5 million by 2034, putting foreign-patient capacity and margins on hospital board agendas.

For UAE hospital CEOs, CFOs and COOs, the takeaway is a 19.63% CAGR for 2026-2034 that will reward operators with accredited specialties, transparent packages and post-discharge systems that work after patients return home.

The forecast and the commercial signal

The openPR release, citing IMARC Group, says the market reached USD 865.8 million in 2025 and is projected to reach USD 4,547.5 million by 2034. The report gives 2026-2034 as the forecast period and 2025 as the base year.

“The UAE medical tourism market size reached USD 865.8 million in 2025.” — IMARC Group, UAE Medical Tourism Market Report by Type, Treatment Type, and Region, 2026-2034

The number is useful, but operators still need to define what revenue they can capture. Market estimates may include hospital bills, hotel stays, wellness packages, travel support and concierge services. A provider can underwrite service lines, not a national forecast. The better test is whether Dubai, Abu Dhabi or Northern Emirates facilities can convert international demand into profitable volumes in dentistry, dermatology, fertility, orthopaedics, oncology second opinions, cardiac care and executive screening.

• IMARC Group puts the 2025 market size at USD 865.8 million.
• IMARC Group forecasts USD 4,547.5 million by 2034.
• IMARC Group gives a 19.63% CAGR for 2026-2034.
• DHA said Dubai received 674,000 medical tourists in 2022, with spending of AED 992 million.

Regulators set the operating floor

Dubai providers operate under the Dubai Health Authority (DHA), Abu Dhabi and Al Ain providers under the Department of Health - Abu Dhabi (DOH), and Northern Emirates providers under the Ministry of Health and Prevention (MOHAP). That split matters because medical tourism crosses borders while licensing, advertising, clinical governance and facility standards remain emirate-specific.

DHA has built a dedicated health-tourism channel through its Dubai Health Experience platform. DHA said Dubai received 674,000 medical tourists in 2022, with spending of AED 992 million. That base shows why volume alone is a weak target. A large visitor count does not prove that a hospital has a profitable international-patient unit.

DOH is explicit about the operating bar in Abu Dhabi. Its Medical Tourism Network standard requires licensed facilities to register the service, maintain AAMEN certification, integrate electronic medical records with Malaffi, publish transparent package pricing and hold relevant international accreditation within 18 months of the standard’s effective date. For COOs and CIOs, medical tourism is a workflow, data and governance project before it is a sales channel.

What operators should watch

The near-term management question is capacity. If the market reaches USD 4.55 billion by 2034, UAE hospitals will need multilingual patient navigation, medical interpreters, overseas-ready discharge summaries and complication protocols for patients who have left the country. Those costs sit in operations before they appear in revenue.

CFOs should test each international-patient package against contribution margin, payer mix and cancellation risk. Medical tourists often ask for fixed prices, fast booking, visa support and hotel coordination. Those features can improve conversion, but weak complication clauses can shift clinical and logistical risk to the provider.

For CEOs, the competitor set already has visible brands. Cleveland Clinic Abu Dhabi, American Hospital Dubai, Mediclinic Middle East, Burjeel Holdings, Aster DM Healthcare and Thumbay-linked services have international recognition. Smaller operators may need referral partnerships, niche specialties or facilitator contracts instead of broad foreign-patient marketing.

The number to remember is USD 4.55 billion by 2034. Until DHA, DOH and MOHAP publish more consistent medical-tourism data on patient origin, specialty, spend, complications and complaints, operators should treat the IMARC Group forecast as a demand signal and build around regulator-ready service lines with measurable margins.